Amiquinsin

This classification denotes an antihypertensive agent with the molecular formula C11H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85HK85C137, chemically known as 4-amino-6,7-dimethoxyquinoline but generally known as amiquinsin, which bears US NIH Compound Identifier 23510. Amiquinsin most often comes in base and hydrochloride forms. European Medicines Agency schedules Amiquinsin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05456MIG. The term AMIQUINSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). AMIQUINSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amiquinsin under HS 29334990 and SITC 51575. As of Q4 2014, AMIQUINSIN remains the US FDA Preferred Term for this commodity. Amiquinsin bears US NLM identifiers UMLS ID C0610917 and NCI Concept Code C79900. SMILES: COC1=CC2=C(C=CN=C2C=C1OC)N.